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Abstract 
Saccharides in our diet are major sources of carbon for the formation of biomass such as 
proteins, lipids, nucleic acids, and glycans. Among the dietary monosaccharides, glucose occupies a 
central role in metabolism, but human blood contains regulated levels of other monosaccharides as well. 
Their influence on metabolism and how they are utilized has not been explored thoroughly. Applying 
metabolic flux analysis on glycan synthesis can reveal the pathways that supply glycosylation precursors 
and provide a snapshot of the metabolic state of the cell. In this study we traced the incorporation of six 
13C uniformly-labeled monosaccharides in the N-glycans, O-glycans, and glycosphingolipids of both 
pluripotent and neural NTERA-2 cells. We gathered detailed isotopologue data for hundreds of 
glycoconjugates using mass spectrometry methods. The contributions of de novo synthesis and direct 
incorporation pathways for glucose, mannose, fructose, galactose, N-acetylglucosamine, and fucose 
were determined based on their isotope incorporation. Co-feeding studies revealed that fructose 
incorporation is drastically decreased by the presence of glucose, while mannose and galactose were 
much less affected. Furthermore, increased sialylation slowed down the turnover of glycans but 
fucosylation attenuated this effect. Our results demonstrated that exogenous monosaccharide 
utilization can vary markedly depending on the cell differentiation state and monosaccharide availability, 
and that the incorporation of carbons can also differ among different glycan structures. We contend 
that the analysis of metabolic isotope labeling of glycans can yield new insights about cell metabolism.   
D
ow
nloaded from
 https://academ
ic.oup.com
/glycob/advance-article-abstract/doi/10.1093/glycob/cw
aa038/5824310 by guest on 09 June 2020
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
Introduction 
Glycans are metabolic products biologically synthesized through non-templated yet highly 
regulated processes. Glycan biosynthesis is carried out by a host of glycosyltransferases and glycosidases 
in the endoplasmic reticulum and the Golgi apparatus. Using just a small set of monosaccharide 
precursors, these enzymes can produce diverse glycan structures which can be elongated with repeating 
saccharide units, have multiple branching points, and express glycan epitopes (Varki and Sharon 2009). 
Cellular precursor monosaccharides can be derived from exogenous carbohydrates, salvaged from 
degraded glycans, converted from other monosaccharides, or synthesized anew through 
gluconeogenesis (Freeze and Elbein 2009; Yarema and Bertozzi 2001). Pathways that convert glucose to 
other glycosylation monosaccharide precursors are present in most cells but may be restricted by other 
factors. The quantitative contributions of each pathway have not been fully elucidated, although several 
factors are now known to affect glycosylation including the cellular type and state, nutrient availability, 
and cell culture conditions (Goochee and Monica 1990; Hossler 2012; Park et al. 2017).  
Glucose is intricately involved in several metabolic pathways, including routes for ATP 
production and those that provide precursors for other biological macromolecules. It is one of the most 
abundant nutrients in human plasma, maintained at levels of around 5.5 mM in healthy subjects. 
However, other monosaccharides are also present in blood at lower levels than glucose. Mannose is 
present at 0.050 – 0.100 mM (Sharma et al. 2014), galactose can vary from about 0.23 - 4.56 mM 
(Williams et al. 1983), and fructose at 0.005 – 0.300 mM (Laughlin 2014).  
Despite their relatively low concentrations, both in vitro and in vivo experiments using 
isotopically labeled precursors have shown that specific monosaccharides such as fucose, mannose, and 
galactose are preferred for glycan biosynthesis. Exogenous mannose at physiological levels can provide 
up to 50% of mannose in the N-glycans of a human fibroblast cell line (Ichikawa et al. 2014). Up to 10% 
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of orally administered galactose incorporated directly into human milk oligosaccharides (Rudloff et al. 
2006). Although fructose is not expressed on glycans, it still a major dietary sugar. High doses of fructose 
can be circulated in the bloodstream and be utilized by cells (Jang et al. 2018; Sun and Empie 2012). We 
have recently reported that the rate of incorporation of exogenous monosaccharides into glycoproteins 
is both glycan-specific and protein-dependent (Xu et al. 2019b). In vivo studies on mice, rats, and chicks 
have shown that intravenously administered radiolabeled fucose incorporate readily into brain 
glycoproteins (Popov et al. 1976; Rose and Harding 1984; Zatz and Barondes 1970). Radiolabeled 
glucose, galactose, and glucosamine were also detected in the glycolipids of juvenile rat brains (Burton 
et al. 1963). These studies illustrate the importance of glycosylation in brain development, especially for 
learning and memory. A more complete understanding of the contributions of glycan biosynthetic 
pathways should entail the utilization of not just glucose, but also other monosaccharides. 
To investigate the utilization of exogenous monosaccharides in a neural model, we induced the 
pluripotent human embryonic carcinoma cell line NTERA-2 to differentiate into glial and neuronal cells, 
then compared the utilization of various monosaccharides towards glycan synthesis before and after 
differentiation by comprehensive glycomic analysis. Differentiation causes dynamic changes in cell 
metabolism. Pluripotent cells are still in a proliferative stage, and their metabolic pathways are geared 
towards anabolic processes to generate the biomass needed for new cells (Vander Heiden et al. 2009). 
Thus, more glucose is metabolized through glycolysis to supply the required precursors for 
macromolecular synthesis. By contrast, differentiated cells further metabolize the glycolytic products 
through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to yield more energy per 
glucose molecule. Metabolic profiling studies have revealed that neurons rely on oxidative metabolism 
for energy, while astrocytes use glycolysis to release lactate that can be taken up by neurons (Bélanger 
et al. 2011). How this metabolic shift affects glycan synthesis has not yet been elucidated. 
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Differentiation can also alter the glycomic landscape on the cell surface, reflecting the evolution 
in the functions of the cell (Hakomori 1981; Lau et al. 2007). Pluripotency is linked to the increased 
expression of N-glycan high mannose structures (Hasehira et al. 2012) and globo-type glycosphingolipid 
(GSL) structures, particularly stage-specific embryonic antigens (SSEA) which are regarded as markers for 
cell pluripotency (Breimer et al. 2017). When differentiated into neural progenitors, GSL expression is 
shifted from globo- and lacto- type structures to sialylated gangliosides (Liang et al. 2011). The 
functional roles of these glycan features are not yet fully understood, although it has been shown that 
SSEA-3 and -4 are not essential to maintain pluripotency in human embryonic stem cells (Brimble et al. 
2007). 
In this study, we profiled the changes in glycosylation that accompany neural cellular 
differentiation. We fed both undifferentiated and differentiated NTERA-2 cells with isotopically labeled 
monosaccharides and quantified their incorporation into cell surface glycans. The glycoconjugates were 
analyzed through a mass-spectrometry based method that combines previously described methods 
(Park et al. 2017; Wong et al. 2018) into a single workflow for N-glycan, O-glycan, and GSL analyses. The 
unified method is benefited by the sensitivity and mass resolution of a chip-based nanoflow Liquid 
Chromatography system coupled to a Quadrupole/Time-of-Flight Mass Spectrometer (nanoLC-Chip-
Q/ToF MS). A more comprehensive profile of the cell surface glycocalyx can thus be obtained from a 
single sample source. By analyzing intact glycans we can track the differential incorporation of 13C into 
individual glycan structures. Detailed quantitative isotopologue profiles were gathered for 112 N-glycan, 
45 O-glycan, and 96 GSL compositions. To our knowledge, this is the most comprehensive isotopic 
labeling analysis of cell-surface glycosylation to date. Through these results we delve into how metabolic 
pathways and glycan synthesis are affected by the availability of various exogenous sugars. We also 
investigate the turnover rates of different types of protein- and lipid-bound glycans, and how 
supplementation of glucose with other monosaccharides affects monosaccharide utilization. 
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Results 
Glycomic characterization of differentiated neural cells 
The pluripotent embryonic cell line NTERA-2 was differentiated into neurons and glial cells by 
exposure to retinoic acid for at least 4 weeks following an established differentiation protocol 
(Thompson et al. 1984). Differentiation was confirmed by morphological changes in the differentiated 
cells such as the agglomeration of neuronal cells and neurite outgrowth, as shown in Supplementary 
Figure S1. To remove undifferentiated cells and obtain a purer culture of neural cells, the differentiated 
neural cells were selectively released and replated with a dilute solution of trypsin. The replated cells 
were exposed to mitotic inhibitors for at least two weeks to prevent the proliferation of undifferentiated 
cells.  
We purified and analyzed the N-glycans, O-glycans, and GSLs from the membrane fractions of 
the pluripotent and neural cells. Annotated glycan chromatogram profiles of NTERA-2 cells are shown in 
Figure 1. The N-glycan profile shows a notable decrease of high mannose structures from a relative 
abundance of 35% to 20% and an increase of sialylated structures from 47% to 58% upon neural 
differentiation. Multiantennary sialylated complex-type structures constituted the majority of N-glycan 
structures in differentiated neural cells. The O-glycans comprised of mostly sialylated core 2 O-GalNAc 
glycans elongated with repeating N-acetyllactosamine units, together with sialylated core 1 glycans. O-
Mannose structures were not detected in appreciable quantities, but the low abundances were due to 
limitations of the method and not necessarily because they were absent from NTERA-2. Globo-type GSLs 
including Gb3, Gb4, and SSEA-3 and -4 were abundant in undifferentiated cells but were mostly 
undetected or found in much lower levels in neural cells. Gangliosides with multiple sialylation such as 
GT1, GD3, GD2, and GD1 also increased in neural cells. The shift in the neural glycomic profile towards a 
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greater abundance and density of sialic acids is in good agreement with published literature, albeit on 
other cell lines (Breimer et al. 2017; Park et al. 2015). 
Patterns of 13C incorporation  
To determine how NTERA-2 cells utilize different monosaccharides for glycan synthesis, we 
separately fed undifferentiated and differentiated neural cells with 5 mM of [13C-UL] glucose, galactose, 
mannose, fructose, or N-acetylglucosamine for 72 h prior to harvest. We also tested different conditions 
with [13C-UL] fucose: 5 mM labeled fucose, 100 µM labeled fucose, and 100 µM labeled fucose with 5 
mM regular glucose. The isotopologue profiles for hundreds of N-glycan, O-glycan, and GSL structures 
were determined with the Agilent Profinder B.08 software, which can also correct for the natural 
distribution of 13C.  
With the introduction of 13C in the form of labeled monosaccharides, the observed m/z signals 
of a target glycan analyte were distributed between the unlabeled molecular ion M and labeled 
molecules with higher m/z values corresponding to M + n, where n is the number of 13C. Because we can 
only observe the mass-to-charge ratio, the observed mass shift would also depend on the charge state: 
the shift due to each 13C is equivalent to 1 amu divided by the charge state z. For example, when n = 6, a 
mass shift of 3 m/z is observed for an ion with z = 2.  
The isotopologue pattern due to the 13C mass shift depended on the metabolic pathways leading 
to the incorporation of the monosaccharide. We identified two distinct patterns of incorporation: intact 
incorporation, which is associated with direct incorporation and salvage pathways; and diffused 
incorporation, which is associated with glycolytic pathways and de novo synthesis of monosaccharides. 
Intact incorporation of uniformly labeled monosaccharides was distinguished by discrete signals every 6 
units after the glycan molecular ion, corresponding to the six labeled carbons in each [13C-UL] 
monosaccharide. Diffused incorporation was characterized by a broad distribution of M + n signals. Both 
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intact and diffused incorporation patterns are illustrated in Figure 2, which shows the isotopologue 
profiles for representative N-glycan, O-glycan, and GSL compounds chosen for their abundance. The 
selected compounds illustrate the trends found in their respective types.  
The monosaccharides glucose, galactose, mannose, and fructose displayed mostly diffused 
incorporation in both undifferentiated pluripotent cells and differentiated neural cells, demonstrating 
that they are broken down through glycolysis before being incorporated back in newly synthesized 
monosaccharides. Lower levels of intact incorporation were also observed for the four hexoses, but to 
varying degrees depending on glycan type and differentiation state. It is noteworthy that their 
isotopologue distribution patterns were vastly dissimilar despite undergoing the same catabolic 
processes. 
In contrast, N-Acetylglucosamine (GlcNAc) and fucose (Fuc) were mostly incorporated intact in 
NTERA-2 cells. GlcNAc was converted to N-acetylgalactosamine (GalNAc) and N-acetylneuraminic acid 
(NeuAc) in pluripotent cells. It displayed conversion to only GalNAc and but not NeuAc in neural cells. 
This effect can be observed in Figure 2B. Here, the GlcNAc-treated undifferentiated sample (6th mass 
spectrum from the top) showed a prominent signal at M + 30, corresponding to the intact incorporation 
of 4 GlcNAc and 1 NeuAc residues in the glycan structure; the same signal was not observed in the 
neural cell sample, indicating that the conversion pathway of GlcNAc to NeuAc is lost after 
differentiation. This same pattern was also observed in other sialylated glycans, including O-glycans and 
GSLs. 
Interestingly, fucose showed only direct incorporation without interconversion to other 
monosaccharides. Fucose incorporation was exceptionally efficient and highly specific. Intact 
incorporation of fucose remained at the same level even when the concentration was lowered from 5 
mM to 100 M. It was also unaffected by the presence of 5 mM glucose.  
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Isotopologue quantitation 
Unique isotopologue profiles were obtained for each analyzed glycan species. We devised some 
metrics to summarize the data and compare them more easily. The percentage of labeling (%L) is the 
simplest measure, and can be calculated by taking the difference between 100% and the corrected M + 
0 relative abundance. However, %L can only indicate how much of a given glycan has incorporated at 
least one 13C from exogenous sources; it does not provide a measure of how many 13C atoms were 
incorporated in a specific glycan. Incorporation of more 13C in a glycan would result in a shift towards 
higher M + n, as can be seen from the isotopologue plots in Figure 2. The %L will also give higher values 
for glycans with more monosaccharide residues because of the cumulative probability of each 
monosaccharide being labeled. Thus, it would display an inherent bias towards N-glycans because they 
typically have more monosaccharide units than O-glycans and GSLs. 
A more meaningful measurement of 13C incorporation would account for the shift isotopologue 
distribution towards higher masses. To make more direct comparisons, we calculated for the percent 
extent of incorporation (%E) as a measure of the completeness of 13C labeling, normalized to the 
number of carbon atoms of the glycan. The %E was defined by the following equation: 
%𝐸 = ∑
𝑛 × (% Corrected Abundance)𝑛
𝑁
𝑁
𝑛=1
 
Where n was the number of 13C in the isotopologue and N was the total number of carbons in 
the glycan. This allowed us to compare not just glycans of different sizes, but also different kinds of 
glycoconjugates.  
A conservative estimate of the extent of intact incorporation (%Ei) was also calculated by 
considering only the M + 6n signals and subtracting the average of the (M + 6n) ± 1 signals to account for 
diffused incorporation and normalizing the signal to the number of carbon atoms. We then calculated 
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for the extent of diffused incorporation (%Ed) by subtracting %Ei from %E. The mean %E of N-glycans, O-
glycans, and GSLs extracted from undifferentiated and neural cells grown with labeled monosaccharides 
are shown in Figure 3A, while Figure 3B shows the mean %Ei and %Ed.  
Here we briefly discuss the sources of error for these measurements. Instrument noise can 
introduce error because we are taking a summation of signals from a large discontinuous range of m/z. 
This is most noticeable in the incorporation values from control samples. Noise will disproportionately 
affect low abundance compounds and larger compounds, which will require a larger m/z range. We 
mitigated this issue by discarding compounds with an area count lower than 100,000 and setting the 
mass tolerance at 10 PPM during peak extraction. We also screened out co-eluting compounds with 
overlapping m/z ranges to avoid erroneous readings. Another source of error was the small amount of 
impurity in the uniformly labeled monosaccharides (99% purity according to manufacturer’s analysis). 
This includes partially labeled monosaccharides, which would lead to the underestimation of intact 
incorporation, %Ei, and concomitantly an overestimation of %Ed. In glycans with particularly high levels 
of intact incorporation in a high number of monosaccharide residues, the signals from partially labeled 
monosaccharides add up and compromise our calculations for %Ei. This effect was observed in high-
mannose N-glycans, but it was not as pronounced in most other structures. We also saw this in the %Ed 
values from samples with labeled fucose although they are only incorporated intact. Despite these 
caveats, the calculated %E values still provide a convenient summary of the data. 
Nature of isotopic incorporation in pluripotent and neural cells 
Undifferentiated pluripotent cells rely more heavily on glycolytic pathways to metabolize 
glucose and other monosaccharides into anabolic precursors. Activated monosaccharides can also be 
utilized directly for glycan synthesis; indeed, this would be more energetically efficient. We calculated 
the contributions from these pathways from the glycan isotopologue profiles of pluripotent and neural 
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cells fed for 72 h with labeled monosaccharides. The carbon contributions from exogenous 
monosaccharides exhibited a wide range among the different glycan structures, from just a few percent 
to about 70% in the largest high mannose N-glycans of fructose-fed pluripotent cells. To compare the 
different conditions, we plotted the mean %E values in Figure 3. Here we note that a considerable 
amount of carbons was not sourced from exogenous monosaccharides. Exogenous glucose provided an 
average of just 16% of the carbons in all three glycoconjugate types in pluripotent cells. This figure was 
at around 26 – 27% in protein-bound glycans and 11% in GSLs after differentiation. We surmise that the 
unlabeled carbons could be derived from the 4 mM glutamine in the growth media. Among the 
monosaccharide-derived carbons, we observed predominantly diffused incorporation patterns from 
exogenous glucose, galactose, mannose, and fructose, suggesting that the monosaccharide precursors 
for glycan synthesis were heavily sourced from the gluconeogenesis of glycolytic products rather than 
intact incorporation of activated monosaccharides. This effect was most pronounced when mannose 
and fructose were provided to pluripotent cells, in which they contributed a mean %Ed of 39% and 57% 
respectively to N-glycans; these figures are 2.6 and 3.8 times greater than that of glucose. Mannose and 
fructose incorporation exhibited the most distinct differences between pluripotent and neural cells. The 
mean %Ed of glucose and galactose both pre- and post-differentiation stood at 15 – 17% in N- and O-
glycans.  
By contrast, intact incorporation of the four hexoses contributed just between 2 – 8% in all 
glycoconjugates. In both pluripotent and neural cells, galactose found a modestly higher level of intact 
incorporation in O-glycans and GSLs, in which its %Ei stood at 6.7 – 8.7% compared to around 2% in N-
glycans. This was due to the prevalence of Gal and GalNAc in these structures. The utilization of 
galactose is regulated by the Leloir pathway (Frey 1996), which converts galactose to glucose; this limits 
the conversion of galactose to other monosaccharides and its access to glycolytic pathways.  
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Delving into the %E of individual glycan structures in Supplementary Figure S2 reveals some 
glycan specificity of intact incorporation. Among GSLs in pluripotent cells, the %Ei of galactose is highest 
in globo-type GSLs, particularly in Gb3, SSEA-3, and SSEA-4 (labeled as 3_0_0_0_0_0_d34_1, 
4_1_0_0_0_0_d34_1, and 4_1_0_1_0_0_d34_1 respectively). The values were comparable only to 
lactosylceramides, which are the common precursors for all GSLs (glycan composition of 2_0_0_0_0_0). 
This indicates a fast rate of synthesis for globo structures since glycolytic steps are avoided.  
Mannose was incorporated intact most rapidly in high-mannose N-glycans, which were 
especially abundant in pluripotent cells. This partially accounted the higher overall %E of mannose in 
pluripotent cells. Incorporation of mannose in N-glycans was notably decreased in neural cells, and a 
bigger share was taken up by O-glycans. Exogenous mannose was shunted heavily towards N-
glycosylation pathways during the proliferative state.  
Fructose presented the highest level of diffused incorporation among all the monosaccharides. 
Its phosphorylated form can readily enter the glycolysis pathway, and its high %Ed implied an increased 
rate of glycolysis and gluconeogenesis in pluripotent cells. This was attenuated after neural 
differentiation. From Supplementary Figure S2, we also observe an %Ei of around 10 – 20% (pluripotent) 
and 5 – 11% (neural) in high mannose N-glycans, indicating that fructose was converted to mannose as 
well.  
The %E in GSLs was generally higher in pluripotent cells than in neural cells, demonstrating a 
faster rate of GSL synthesis in the proliferative pluripotent cells. In GSLs, glucose and fructose also 
shifted from diffused to intact incorporation after neural differentiation, as seen in Figure 2D. The 
incorporation of galactose and mannose in GSLs remained mostly intact. Glycolytic products from 
glucose and fructose might also be utilized for lipid synthesis in GSLs as seen in their diffused 
incorporation patterns, although the contribution from this pathway seemed to be low. It is also notable 
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that the contribution of glycolytic pathways to GSLs after differentiation was more moderate compared 
to N-glycans and O-glycans, although intact incorporation remained at similar levels.  
Fucose (Fuc) exhibited only intact incorporation and showed no glycolytic contributions towards 
glycan synthesis even in the absence of glucose. N-Acetylglucosamine (GlcNAc) had only very low levels 
of diffused incorporation without glucose. Note that the small value of %Ed in the fucose data presented 
in Figure 3B was due to signal noise and the underestimation of intact incorporation as described in the 
previous section. The %Ei of GlcNAc in N- and O-glycans was relatively higher at 12 – 13% in pluripotent 
cells because of its conversion to GalNAc and NeuAc. However, conversion of GlcNAc to NeuAc was 
massively reduced post-differentiation, despite the heavy sialylation of the neural glycome. This effect 
suggested a loss of UDP-GlcNAc 2-epimerase activity (Keppler et al. 1999) and perhaps an efficient 
salvage pathway for sialic acids. The specificity of fucose incorporation remained unchanged although 
lower levels were found after differentiation. The observed monosaccharide interconversions were in 
line with known pathways and further highlight the unique routes taken by fucose and GlcNAc towards 
incorporation.  
Co-feeding studies demonstrate the effect of glucose levels on monosaccharide utilization 
Co-feeding studies were performed to better simulate the extracellular environment in 
mammals, where the supply of glucose is well-regulated by complex biological systems (Cura and 
Carruthers 2011). Human blood glucose levels are maintained at 5.5 mM in healthy individuals, and 
deviations induce rapid homeostatic responses to restore normal levels. To test how cells utilize other 
monosaccharides under hypoglycemic conditions, pluripotent cells were provided with 0, 0.10 mM, 0.25 
mM, 0.50 mM, 1 mM, or 5 mM of normal glucose together with 5 mM of either [13C-UL] galactose, 
mannose, or fructose for 24 h. The N-glycan isotopologue data are summarized in Figure 4A, and 
representative isotopologue profiles from one of the more abundant glycans, Hex5HexNAc4Fuc1NeuAc1, 
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are shown in Figure 4B. The %Ei and %Ed of individual glycan compositions are plotted in 
Supplementary Figure S3.  
The effect of exogenous glucose on the utilization of galactose, mannose, and fructose in N-
glycans differed markedly. At exogenous glucose levels of 0 – 1 mM, galactose had a relatively low 
diffused incorporation at 3.8 – 5.3% and it was mostly incorporated intact, with a mean %Ei of 3.7. 
Galactose was also observed to be converted to other hexoses, as illustrated by the signals at M + 18 
and M + 24 in the first 5 isotopologue plots in the first column of Figure 4B. These signals are lost in the 
bottommost plot. The high %Ei : %Ed ratio was consistent with the Leloir pathway, which converts 
galactose to UDP-galactose and UDP-glucose (Frey 1996). 
At 5 mM glucose, the conversion of galactose was minimized and was mostly directly 
incorporated; the same effect was observed in all glycans. The utilization of mannose remained largely 
unaffected even at 5 mM Glc, with an %Ed of around 25% and an %Ei of 6.0 – 7.8%. Mannose also 
displayed interconversion at all glucose levels, showing that its utilization was relatively insensitive to 
the presence of glucose.  
On the other hand, the %Ed of fructose decreased with increasing glucose concentration. The 
%Ed and %Ei of fructose at low glucose concentrations were at around 20% and 8% respectively, 
comparable to mannose. At 5 mM glucose, the overall incorporation of fructose was vastly minimized to 
less than 3%. Fructose utilization showed the most sensitivity to glucose supplementation.  
The uniformity of the %Ei : %Ed ratio for the mannose-glucose and fructose-glucose 
combinations suggested that the initial action of hexokinase was the limiting factor, rather than the 
epimerases/isomerases that convert mannose-6-phosphate and glucose-6-phosphate to fructose-6-
phosphate (Freeze and Elbein 2009). These results implied that the hexokinase had a stronger 
preference for mannose over glucose, and the least for fructose. 
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Time-course studies yield differential incorporation in glycan types 
Time-course experiments further revealed the rates of synthesis and glycan turnover. In this 
study, the concentration of labeled glucose was matched to the level in the DMEM growth medium at 
25 mM. Although this is higher than the physiological level of 5 mM, it allowed for a higher level of 13C 
incorporation within the 24 h timeframe and better quantitation of isotopologues. Undifferentiated cells 
were provided with 25 mM [13C-UL] glucose for 3, 6, 9, 12, 18, and 24 h prior to harvest. The rates of 
synthesis of new glycans can be observed within this 24 h timeframe. Figure 5 illustrates the mean %Ei 
and %Ed for N- and O-glycans as well as GSLs. The incorporation shifted towards a higher M + n over 
time and towards higher abundance of labeled isotopologues, leading to an increase in %E. The increase 
of diffused incorporation was much faster than that of intact incorporation. The %Ed in N-glycans 
continued to increase for 24 h at a rate of 1.8% per hour, while it plateaued at 18 h in O-glycans and 
GSLs at rates of 1.4% per hour and 0.9% per hour respectively. The %Ei increased at a rate of only 0.2%, 
0.4%, and 0.3% per hour for N-glycans, O-glycans, and GSLs respectively, although we must note that 
the %Ei was underestimated especially for high-mannose structures.  
Differential incorporation rates were observed among different subtypes. Glycans with the 
highest rates also displayed the most intact incorporation, and these were mostly the precursors of each 
type: high-mannose structures in N-glycans, and the GSL precursors monohexosylceramide and 
lactosylceramide. Globo-type GSLs also displayed higher levels of intact incorporation than gangliosides, 
as shown in Supplementary Figure S4. 
In N-glycans, the rates of incorporation followed the maturity of N-glycans. As shown in Figure 
6B, incorporation was fastest in high-mannose structures, followed by hybrid  and then complex 
structures as expected from the N-glycan biosynthetic pathway (Kornfeld and Kornfeld 1985; Stanley et 
D
ow
nloaded from
 https://academ
ic.oup.com
/glycob/advance-article-abstract/doi/10.1093/glycob/cw
aa038/5824310 by guest on 09 June 2020
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
al. 2015). The incorporation curve of complex- and hybrid- type N-glycans (Figure 6B) was similar to that 
of the paucimannose structure GlcNAc2Man3 (Figure 6A), suggesting that the trimming of mannoses 
through the successive activity of mannosidases determined the rate of N-glycan formation. 
Hybrid- and complex-type N-glycans reached mean %E of 50% and 40% respectively after 24 h. 
Higher antennarity in complex-type N-glycans led to slower incorporation as expected from the N-glycan 
biosynthetic pathway. Increased sialylation led to slower turnover rates, and this effect was most 
apparent in tri-antennary N-glycans; however, core fucosylation modulated this behavior, as shown in 
Figure 6C. The trend was also observed among bi-antennary N-glycans as well as sialylated O-glycans. 
These results suggest that sialylation and core fucosylation both play a role in glycoprotein turnover. The 
decreasing effect of sialylation on glycan turnover was also observed in previous work on a hepatic 
cholangiocarcinoma cell line M213 (Xu et al. 2019a). 
In GSLs, the main determinant of incorporation rate was the length of the ceramide N-linked 
fatty acid, as shown in Figure 6D. For GSLs with the same glycan headgroups, a shorter lipid length led to 
higher incorporation and therefore faster turnover compared to those with a longer fatty acid chain, 
consistent with the results reported by Skotland et al. (Skotland et al. 2016).  
Reproducibility 
To estimate the reproducibility of the experiment, 2 biological replicates were performed for the 
provision of 5 mM [13C-UL] glucose, mannose, and fructose to undifferentiated NTERA-2 for 24 h. 
Triplicates were performed for labeled galactose. Unfortunately, replicates could not be accomplished 
for all the conditions in the experiment due to the cost of isotopically labeled reagents. Biological 
replicates were grown from the same passage of cells. In general, the glycomic profiles were similar 
among replicates. The 13C incorporation patterns and relative quantities were also largely similar among 
the replicates. The calculated %E for each N-glycan composition are plotted in Supplementary Figure S5, 
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with error bars representing the standard deviation (SD). Compounds with higher abundances and 
higher levels of incorporation had lower standard deviations. An average of around 5% SD was 
calculated for the %E among the different glycans in biological duplicates, showing that the 
incorporation of 13C and isotopologue quantitation method presented are reproducible. 
Discussion 
Akin to metabolic flux analysis, studying how exogenous monosaccharide precursors are 
incorporated into glycans can reveal the pathways taken by the monosaccharides and provide a 
snapshot of the metabolic state of the cell. Most of the metabolic analyses reported using 13C stable 
isotope labeling have focused on small molecule metabolites such as amino acids or phosphorylated 
monosaccharides (Dalman et al. 2016; Ichikawa et al. 2014; Zamboni et al. 2009). The application of 
stable isotope tracers to macromolecules such as oligosaccharides and glycolipids presented new 
challenges. First, a broader range of m/z values must be monitored corresponding to the number of 
carbons in the analyte, leading to a greater chance of isotopologue signal overlap. Second, the 
distribution of the target analyte among multiple isotopologues could diminish signal intensity by an 
order of magnitude or more. These challenges can be addressed by good chromatographic separation 
and sensitive detection. Nanoflow LC-MS using a chip-based enrichment and analytical column coupled 
to a time-of-flight (TOF) MS has proven to be up to the task and was the implement of choice for this 
study. Finally, the deconvolution of the natural isotopic distribution of a large biomolecule was 
necessary to tease out the contributions of exogenous isotope labeling. Valkenborg and others offer an 
excellent review of modern computational methods to address this problem (Valkenborg et al. 2012). 
The Agilent Profinder B.08 software provided the much-needed algorithm for this deconvolution.  
We observed two patterns in the corrected/deconvoluted isotopologue profiles. The sharp and 
distinct mass shifts corresponding to 6 carbons were easily discernible as the intact incorporation of 
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monosaccharides. The broad distributions, which we described as diffused incorporation, signaled that 
the glycan analyte contained a mix of monosaccharide residues with different numbers of labeled 
carbons. The monosaccharide residues were synthesized not just from glycolytic pyruvate, which would 
result in uniform mass shifts of 3 units. The gluconeogenesis pathway could also take its precursors from 
the intermediates in the TCA cycle or the breakdown of recycled amino acids which have incorporated 
the labeled carbons, resulting in hexoses with 2, 3, 4, or 5 labeled carbons. By taking the summation of 
these corrected isotopologue signals, we were able quantify the amount of glycolytic metabolites that 
feed into the gluconeogenesis pathway (Exton 1972).  
The provision of 5 mM labeled glucose for 72 h yielded only an average of 16% incorporation in 
the protein-bound glycans of pluripotent cells and up to 27% in neural cells, showing that other carbon 
sources such as glutamine in the growth medium can also contribute heavily to glycan synthesis. In both 
differentiation states, the contribution from the intact incorporation of exogenous glucose was notably 
much lower than from diffused incorporation; the same was true for galactose, mannose, and fructose 
when supplied without glucose. These monosaccharides were effectively shunted to glycolytic pathways 
in both pluripotent and neural NTERA-2 cells, with relatively smaller amounts left for glycan synthesis. 
Our results further demonstrated that the neural NTERA-2 still retained much of the metabolic 
machinery of its undifferentiated pluripotent state despite the vestiges of neural morphology and 
glycome. 
We are likely observing the byproducts of the Warburg effect, the phenomenon by which cells 
perform enhanced glycolysis even in aerobic conditions (Warburg 1956). It has been postulated that this 
is mainly for the provision of carbons to generate biomass (Lunt and Vander Heiden 2011). Human 
embryonic stem cells and induced pluripotent stem cells also exhibit increased glycolysis similar to the 
Warburg effect (Varum et al. 2011). Nevertheless, the circuitous path of monosaccharide degradation 
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and de novo synthesis was a surprising result because gluconeogenesis is a costly process in terms of 
energy, and its regulation is reciprocal to glycolysis. 
The isotopologue distributions offered some clues to this seeming contradiction. Diffused 
incorporation patterns occur when monosaccharides utilized for glycan synthesis source their carbons 
from the intermediates of the TCA cycle or their products. In intact GSLs, minimal glycolytic flux to the 
lipid portion was observed. We posit that the glycolytic flux went mostly towards amino acid synthesis. 
The time-course results showed that precursor glycan structures such as N-glycan high-mannose glycans 
used mostly intact monosaccharides even after 24 h, but the proportion of diffused incorporation was 
higher for those with slower incorporation rates such as complex N-glycans. In other words, exogenous 
monosaccharides were more likely to be incorporated intact in less mature glycans, which are usually 
built up in the endoplasmic reticulum. Taken together, these results suggested that there could be 
separate sublocalization of monosaccharides from exogenous sources and from gluconeogenesis that 
feed into different pools. The possibility of having multiple pools of monosaccharide derivatives from 
different sources has been suggested previously (Ichikawa et al. 2014).  
It is important to note that the differentiated NTERA-2 cultures contained a mix of glial and 
neuronal cells, and the monosaccharide utilization of each cell type cannot be distinguished. Further 
studies are needed to elucidate the metabolic crosstalk and codependence between glial and neuronal 
cells.  
In this work, we studied the changing glycome of pluripotent NTERA-2 cells undergoing neural 
differentiation through mass-spectrometry based glycan analysis. We also traced the contributions of 
glycolytic and direct incorporation pathways towards glycan synthesis by integrating stable isotope 
labeling into the analytical platform. The 13C incorporation profiles of both pluripotent and neural cells 
indicated a Warburg-like metabolic state. The results further suggest that sialylation and core 
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fucosylation could affect glycoprotein turnover.  The analytical workflow for the stable isotope labeling 
of glycans provides another piece of the puzzle in the fluxomic analysis of the whole cell. In future 
studies, the assay can be further applied towards studying the effect of various stimuli on carbohydrate 
utilization and other related systems.  
Methods 
Cell culture. Human pluripotent testicular embryonal carcinoma NTERA-2 cells (RRID: CVCL_3407) 
were obtained from American Type Culture Collection and cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM), supplemented with 10% (v/v) fetal bovine serum (Gibco), and 100 U/ml penicillin and 
100 g/ml streptomycin (Gibco). Cells were grown in 100 mm cell culture dish. The medium was 
replaced every 2-3 days, and cells were subcultured on reaching around 80% confluence using 0.05% 
trypsin (Gibco). Cells were grown in at 37 C in a humidified incubator with 5% CO2.  
13C-labeled monosaccharide feeding. For a set number of hours prior to harvest, the growth 
media is changed to a glucose-free formulation of DMEM supplemented with the appropriate [13C-UL] 
monosaccharide (Omicron Biochemicals) or a combination of uniformly labeled and naturally labeled 
monosaccharides. The growth medium was supplemented with penicillin and streptomycin, but not 
fetal bovine serum to avoid the presence of other exogenous monosaccharides. For the hexoses glucose, 
galactose, mannose, and fructose, a concentration of 5mM was chosen so that a comparison can be 
made at the physiological level of glucose. Undifferentiated cells were given labeled monosaccharides at 
approximately 80% confluence and were collected at 100% confluence. It should be noted that the [13C-
UL] monosaccharides have a of 99% and would contain some incompletely labeled compounds that can 
ultimately lower the extent of incorporation.  
Neural differentiation. We followed a procedure adapted from Pleasure (Pleasure et al. 1992). 
Neural differentiation was induced in NTERA-2 cells by supplementing the growth medium with 0.01 
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mM trans-retinoic acid for at least 4 weeks. Neuronal and glial NTERA-2 cells were selectively detached 
and replated by using 0.025% trypsin and delivering ten hard taps to both sides of the T75 culture flask. 
Replated cells were maintained with growth medium supplemented with the following mitotic inhibitors: 
1 M cytosine arabinoside, 10 M fluoro-deoxyuridine, and 10 M uridine. Differentiated cells were 
maintained with mitotic inhibitors for at least 2 weeks before the introduction of labeled 
monosaccharides. 
Membrane extraction. Harvested cells were suspended in homogenization buffer containing 
1:100 protease inhibitor cocktail set V (Calbiochem), 0.25 M sucrose, and 20 mM HEPES, with the pH 
adjusted to 7.5 using KOH. The cells were lysed with a probe sonicator. Nuclear fractions were pelleted 
and discarded through centrifugation at 2,000  g for 10 min. Membrane fractions were then pelleted 
and separated from other subcellular components through a series of ultracentrifugation steps at 
200,000  g for 45 min. This approach has previously been shown to yield a pure membrane fraction 
based on SDS-PAGE gel electrophoresis and Western blotting using organelle-specific antibodies (An et 
al. 2012); the contributions from ER and Golgi membranes were shown to be minimal.  
Unified N-glycan, O-glycan, and glycolipid extraction. Pelleted membrane fractions were 
resuspended in 100 l of 5 mM dithiothreitol in 100 mM phosphate buffer adjusted to a pH of 7. 
Proteins were denatured by heating at 100C for 1 min. N-glycans were released enzymatically by 
digesting with 2 l of peptide N-glycosidase F (New England Biolabs) at 37C for 18 h. Samples were 
then ultracentrifuged at 200,000 g for 45 min. From the supernatant, N-glycans were purified through 
porous graphitized carbon (PGC) solid phase extraction (SPE). The pellet was washed with 500 l of a 
mixture of 3:8:4 (v/v/v) water/methanol/chloroform Folch solvent (Folch et al. 1957) and centrifuged to 
separate the pelletized proteins from the dissolved lipids in the supernatant. To the supernatant, 100 l 
of 0.1 M potassium chloride was added to cause phase separation between the water- and methanol-
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rich upper layer, which contains mostly GSLs, and the chloroform-rich lower layer, which contains 
mostly other lipids such as cholesterol and phospholipids. The upper Folch layer was collected, and GSLs 
were purified using C8 SPE. O-glycans were released from the pelletized proteins through beta 
elimination reaction using 200 l of 0.1 M NaOH and 1 M NaBH4 for 18 h. The reaction was quenched by 
adding 115 l of 10% acetic acid. O-glycans were purified by PGC SPE followed by hydrophilic interaction 
liquid chromatography (HILIC) SPE.  
NanoHPLC Chip-Q-TOF MS analysis. All samples were analyzed with an Agilent 6520 Accurate 
Mass Q-TOF LC/MS equipped with a microfluidic chip, which incorporates an enrichment column, an 
analytical column, and a nanoelectrospray tip in a single assembly. Purified N-glycan and O-glycan 
samples were separately reconstituted in 30 l water and analyzed with a PGC chip. The binary gradient 
consisted of (A1) 0.1% formic acid and 3% acetonitrile in water, and (B1) 1% formic acid and 89% 
acetonitrile in water. The LC was programmed to hold the solvent composition at 100% A1 from 0-2.5 
min, linearly ramp to 16% B1 at 20 min, and further increase B1 to 58% at 35 min at a constant flow rate 
of 0.3 l/min. For isotopologue data acquisition, the Q-TOF MS was set to acquire only MS1 in positive 
ionization mode with a cycle time of 1.5 s. To assist with compound identification, control samples were 
also run with collision-induced dissociation (CID) using nitrogen gas. Four MS2 spectra were obtained for 
every MS1 through data-dependent acquisition, with a total cycle time of 5.25 s. The mass range was set 
at 600-2000 m/z for N-glycan analysis, and at 300-2000 m/z for O-glycan analysis. The instrument was 
calibrated with the ESI tuning mix commercially available from Agilent. 
Purified intact GSL samples were reconstituted in 50 l 1:1 methanol/water and analyzed with a 
C18 microfluidic chip. A binary gradient consisting of (A2) 20 mM ammonium acetate and 0.1% acetic 
acid in water, and (B2) 20 mM ammonium acetate and 0.1% acetic acid in 85:15 (v/v) 
methanol/isopropanol was used to separate the GSLs at a flow rate of 0.3 l/min. The acquisition 
method was programmed to increase the percentage of B2 from 70% to 85% over 4 min, then to 100% 
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at 40 min. The Q-TOF MS was programmed with the same parameters as stated above. The mass range 
was set at 600-2000 m/z for GSL analysis. In all acquisition methods, the columns were flushed with 
100% of solvent B for 10 min and equilibrated with the initial solvent composition for another 10 min 
prior to sample injection.  
Data processing and isotopologue analysis. We used Agilent MassHunter B.07 software for 
initial data processing and compound peak identification. In brief, compound peaks are extracted by 
matching MS signals with theoretical monoisotopic masses of glycans to within 10 ppm mass tolerance. 
The assignments are further confirmed by MS2 fragmentation when available. From the exported data, 
we then create a new library containing the chemical formulae and retention times of identified 
glycoconjugates for targeted isotopologue extraction. The Agilent Profinder B.08 software was used to 
extract quantitative isotopologue data for each identified glycan through its Batch Isotopologue Analysis 
function. The program averages the MS signals across a chosen peak in an extracted ion chromatogram 
to form the MS spectra from which isotopologue signals are extracted. It also corrects for the natural 
distribution of 13C and returns the relative abundance of each isotopologue. Mass tolerance was set at ± 
(10 ppm + 2 mDa) to screen out background noise or signals from other co-eluting compounds. For each 
glycan, the percent abundance of each isotopologue signal from M + 0 to M + n, where n is the total 
number of carbons in the glycan, can then be exported for further analysis. 
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Legends to Figures 
Figure 1: Extracted compound chromatograms of NTERA-2, showing (A) N-glycan, (B) O-glycan, 
and (C) GSL profiles of (1) undifferentiated and (2) neural cells. Peaks are colored by glycan subtypes and 
annotated with the schematic representations of the glycan structures. The GSL ceramide portions are 
denoted by the number of hydroxyl groups (d or t for di- or tri-hydroxy), total length of lipid, and the 
number of unsaturation. For example, d34:1 describes a ceramide with 2 hydroxyl groups, 34 total 
carbons, and 1 unsaturation. Glycan structures were drawn with GlycoWorkbench (Ceroni et al. 2008). 
Monosaccharide symbols follow the SNFG (Symbol Nomenclature for Glycans) system (Varki et al. 2015). 
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Figure 2: (A) Profile mass spectra of the [M+2H]2+ ion of an N-glycan with composition 
Hex5HexNAc4Fuc1NeuAc1 from undifferentiated NTERA-2 cells. Because doubly charged species are 
shown, the mass shift due to 13C labeling is 0.5 Da per labeled carbon. The mass spectra are corrected 
for the natural isotope distribution of carbon; the corresponding corrected isotopologue data are shown 
in the first column of (B). Corrected isotopologue data are also shown for the following representative 
glycans of each type of glycoconjugate: (B) N-glycan, Hex5HexNAc4Fuc1NeuAc1; (C) O-glycan, 
Hex2HexNAc2NeuAc1; and (D) GSL, GM2(d34:1). Plots are shown for cells grown with regular glucose (ctrl) 
and [13C-UL] monosaccharides (5 mM glucose, 5 mM galactose, 5 mM mannose, 5 mM fructose, and 100 
uM fucose). 
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Figure 3: (A) Mean values for the extent of incorporation %E for N-glycans, O-glycans, and 
glycosphingolipids in both undifferentiated (blue) and neural (red) cells. The cells were fed with 5 mM of 
the indicated labeled monosaccharide for 72 h except for fucose, which was given 100 µM. Error bars 
indicate standard errors for identified glycans, with the N shown in blue text above each bar plot. Note 
that the GlcNAc values include only glycans with GlcNAc, GalNAc, and NeuAc, while fucose values 
include only fucosylated glycans because of the specificity of their incorporation. No fucosylated GSLs 
were detected. (B) Stacked bar plots showing the contribution of diffused incorporation %Ed (dotted 
pattern) and intact incorporation %Ei (solid pattern). Plots for individual glycan compositions are shown 
in Supplementary Figure S2. 
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Figure 4: (A) Mean values for the extent of diffused incorporation %Ed and the extent of intact 
incorporation %Ei for N-glycans. Their sum represents the total extent of incorporation %E. Standard 
errors are shown for N ≈ 200 glycans. Plots for individual glycan compositions are shown in 
Supplementary Figure S3. (B) Isotopologue profiles for the bi-antennary complex N-glycan 
Hex5HexNAc4Fuc1NeuAc1 during co-feeding of 5mM [
13C-UL] galactose, mannose, or fructose with 
normal glucose at concentrations of 0, 0.10, 0.25, 0.50, 1.00, and 5.00 mM. Monosaccharide symbols 
are as follows: Mannose (green circle); Galactose (yellow circle); N-acetylneuraminic acid (NeuAc, pink 
diamond); N-acetylglucosamine (GlcNAc, blue square); Fucose (red triangle).  
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Figure 5: Mean values for the extent of diffused incorporation %Ed and the extent of intact 
incorporation %Ei for N-glycans, O-glycans, and GSLs. Standard errors are shown for the number of 
glycans listed in blue above each bar plot. 
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Figure 6: Incorporation curves showing the extent of incorporation %E plotted against time. (A) 
High-mannose type N-glycans (B) The mean %E of N-glycans grouped by subtype: C = complex, H = 
hybrid, C/H = complex/hybrid, HM = high-mannose. Error bars represent the standard error among the 
N-glycans of each subtype. N(C) = 95, N(C/H) = 76, N(H) = 29, N(HM) = 30. (C) Incorporation curves for 
triantennary complex-type N-glycans with 1-3 NeuAc and 0-1 Fuc. (D) Ganglioside GM2 with 32, 34, 36, 
and 42 ceramide carbons. N-Glycan composition legend: Hex_HexNAc_Fuc_NeuAc; GSL comp. legend: 
Hex_HexNAc_Fuc_NeuAc_NeuGc_Sulf_Ceramide lipid length_Degree of unsaturation. 
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